These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9809028)

  • 1. Molecular and biological features of two new human squamous and adenocarcinoma of the lung cell lines.
    Gasperi-Campani A; Roncuzzi L; Ricotti L; Lenzi L; Gruppioni R; Sensi A; Zini N; Zoli W; Amadori D
    Cancer Genet Cytogenet; 1998 Nov; 107(1):11-20. PubMed ID: 9809028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosomal alterations, biological features and in vitro chemosensitivity of SCLC-R1, a new cell line from human metastatic small cell lung carcinoma.
    Gasperi-Campani A; Roncuzzi L; Zoli W; Lenzi L; Gruppioni R; Sensi A; Zini N; Farabegoli F; Amadori D
    Eur J Cancer; 1998 Apr; 34(5):724-30. PubMed ID: 9713281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular genetics and in vitro sensitivity of a new human cell line, KKP, from a gastric adenocarcinoma.
    Zoli W; Ricotti L; Lenzi L; Roncuzzi L; Zini N; Amadori D; Gruppioni R; Sensi A; Gasperi-Campani A
    Cancer Genet Cytogenet; 1998 Aug; 105(1):43-9. PubMed ID: 9689929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significance of NSE and CEA as a differentiation marker for the cellular heterogeneity of small cell lung cancer.
    Kobayashi S; Okada S; Hasumi T; Sato N; Fujimura S
    Tohoku J Exp Med; 1999 Sep; 189(1):37-49. PubMed ID: 10622207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical and prognostic significance of tumor markers cytokeratin 19 fragment, carcinoembryonic antigen, and neuron-specific enolase in lung cancer].
    Zemaitis M; Sakalauskas R; Malakauskas K; Muley T; Fischer JR; Lahm H
    Medicina (Kaunas); 2005; 41(7):566-76. PubMed ID: 16062024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiling of cultured human bronchial epithelial and lung carcinoma cells.
    Hellmann GM; Fields WR; Doolittle DJ
    Toxicol Sci; 2001 May; 61(1):154-63. PubMed ID: 11294986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of serum tumor markers in patients with lung cancer.
    Hatzakis KD; Froudarakis ME; Bouros D; Tzanakis N; Karkavitsas N; Siafakas NM
    Respiration; 2002; 69(1):25-9. PubMed ID: 11844959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment and characterization of two new cell lines derived from human metastatic breast carcinomas.
    Zoli W; Roncuzzi L; Zini N; Lenzi L; Gruppioni R; Barzanti F; Sensi A; Amadori D; Gasperi-Campani A
    Breast Cancer Res Treat; 1997 Apr; 43(2):141-51. PubMed ID: 9131270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipase member H is a novel secreted protein selectively upregulated in human lung adenocarcinomas and bronchioloalveolar carcinomas.
    Seki Y; Yoshida Y; Ishimine H; Shinozaki-Ushiku A; Ito Y; Sumitomo K; Nakajima J; Fukayama M; Michiue T; Asashima M; Kurisaki A
    Biochem Biophys Res Commun; 2014 Jan; 443(4):1141-7. PubMed ID: 24380866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of inflammasomes in lung cancer cell lines and tissues.
    Kong H; Wang Y; Zeng X; Wang Z; Wang H; Xie W
    Tumour Biol; 2015 Sep; 36(10):7501-13. PubMed ID: 25910707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PD-L1 Is Upregulated by Simultaneous Amplification of the PD-L1 and JAK2 Genes in Non-Small Cell Lung Cancer.
    Ikeda S; Okamoto T; Okano S; Umemoto Y; Tagawa T; Morodomi Y; Kohno M; Shimamatsu S; Kitahara H; Suzuki Y; Fujishita T; Maehara Y
    J Thorac Oncol; 2016 Jan; 11(1):62-71. PubMed ID: 26762740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokeratin 19 fragment CYFRA 21-1 compared with carcinoembryonic antigen, squamous cell carcinoma antigen and neuron-specific enolase in lung cancer. Results of an international multicentre study.
    Ebert W; Dienemann H; Fateh-Moghadam A; Scheulen M; Konietzko N; Schleich T; Bombardieri E
    Eur J Clin Chem Clin Biochem; 1994 Mar; 32(3):189-99. PubMed ID: 7518259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical and molecular characterization of clear cell carcinoma of the lung.
    Yousem SA
    Hum Pathol; 2013 Nov; 44(11):2467-74. PubMed ID: 24029707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-localisation of Glandular and Squamous Cell Markers in Non-small Cell Lung Cancer.
    Koyi H; Brandén E; Kasim I; Wilander E
    Anticancer Res; 2018 Jun; 38(6):3341-3346. PubMed ID: 29848682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Karyotypic characterization of established cell lines derived from a squamous cell carcinoma and an adenocarcinoma of human lung cancers.
    Erdel M; Peter W; Spiess E; Trefz G; Ebert W
    Cancer Genet Cytogenet; 1990 Oct; 49(2):185-98. PubMed ID: 2208054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amplification of the N-myc oncogene in an adenocarcinoma cell line of the lung.
    Kashii T; Mizushima Y; Nakagawa K; Monno S; Yano S
    Anticancer Res; 1992; 12(3):621-4. PubMed ID: 1622116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next-Generation Sequencing of a Cohort of Pulmonary Large Cell Carcinomas Reclassified by World Health Organization 2015 Criteria.
    Driver BR; Portier BP; Mody DR; Deavers M; Bernicker EH; Kim MP; Teh BS; Santacruz JF; Kopas L; Munden RF; Cagle PT
    Arch Pathol Lab Med; 2016 Apr; 140(4):312-7. PubMed ID: 26430808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of role of Notch3 signaling pathway in human lung cancer cells.
    Hassan WA; Yoshida R; Kudoh S; Motooka Y; Ito T
    J Cancer Res Clin Oncol; 2016 May; 142(5):981-93. PubMed ID: 26838758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADAM8 as a novel serological and histochemical marker for lung cancer.
    Ishikawa N; Daigo Y; Yasui W; Inai K; Nishimura H; Tsuchiya E; Kohno N; Nakamura Y
    Clin Cancer Res; 2004 Dec; 10(24):8363-70. PubMed ID: 15623614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of PIK3CA mutations, including a novel mutation of V344G in exon 4, in metastatic lung adenocarcinomas: A retrospective study of 115 FNA cases.
    Allison DB; Lilo MT; Geddes S; Pallavajjalla A; Askin F; Gabrielson E; Zheng G; Li QK
    Cancer Cytopathol; 2016 Jul; 124(7):485-92. PubMed ID: 27007084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.